243 related articles for article (PubMed ID: 30905766)
1. Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy.
Malcolm JC; Breuillaud L; Do Carmo S; Hall H; Welikovitch LA; Macdonald JA; Goedert M; Cuello AC
Neurobiol Dis; 2019 Jul; 127():323-338. PubMed ID: 30905766
[TBL] [Abstract][Full Text] [Related]
2. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
4. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.
Emmerson JT; Do Carmo S; Liu Y; Shalhoub A; Liu A; Bonomo Q; Malcolm JC; Breuillaud L; Cuello AC
Neurobiol Dis; 2023 Aug; 184():106227. PubMed ID: 37454780
[TBL] [Abstract][Full Text] [Related]
5. Transmission and spreading of tauopathy in transgenic mouse brain.
Clavaguera F; Bolmont T; Crowther RA; Abramowski D; Frank S; Probst A; Fraser G; Stalder AK; Beibel M; Staufenbiel M; Jucker M; Goedert M; Tolnay M
Nat Cell Biol; 2009 Jul; 11(7):909-13. PubMed ID: 19503072
[TBL] [Abstract][Full Text] [Related]
6. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
7. Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.
Kovacs GG; Kwong LK; Grossman M; Irwin DJ; Lee EB; Robinson JL; Suh E; Van Deerlin VM; Lee VM; Trojanowski JQ
Brain Pathol; 2018 Mar; 28(2):274-283. PubMed ID: 28019685
[TBL] [Abstract][Full Text] [Related]
8. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
9. Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies.
Wilhelmus MM; de Jager M; Rozemuller AJ; Brevé J; Bol JG; Eckert RL; Drukarch B
J Pathol; 2012 Jan; 226(1):132-42. PubMed ID: 22009441
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
11. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
12. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
[TBL] [Abstract][Full Text] [Related]
13. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers.
Wallon D; Boluda S; Rovelet-Lecrux A; Thierry M; Lagarde J; Miguel L; Lecourtois M; Bonnevalle A; Sarazin M; Bottlaender M; Mula M; Marty S; Nakamura N; Schramm C; Sellal F; Jonveaux T; Heitz C; Le Ber I; Epelbaum S; Magnin E; Zarea A; Rousseau S; Quenez O; Hannequin D; Clavaguera F; Campion D; Duyckaerts C; Nicolas G
Acta Neuropathol; 2021 Aug; 142(2):259-278. PubMed ID: 34095977
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of Tau-P301L transgenic mice reveals no cognitive impairments at 17 months of age.
Kent BA; Heath CJ; Kim CH; Ahrens R; Fraser PE; St George-Hyslop P; Bussey TJ; Saksida LM
Brain Behav; 2018 Jan; 8(1):e00896. PubMed ID: 29568692
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
17. Analysis of tauopathies with transgenic mice.
Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral delivery of the human wild-type tau protein mediates a slow and progressive neurodegenerative tau pathology in the rat brain.
Caillierez R; Bégard S; Lécolle K; Deramecourt V; Zommer N; Dujardin S; Loyens A; Dufour N; Aurégan G; Winderickx J; Hantraye P; Déglon N; Buée L; Colin M
Mol Ther; 2013 Jul; 21(7):1358-68. PubMed ID: 23609018
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.
Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM
Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524
[TBL] [Abstract][Full Text] [Related]
20. Tauopathies as clinicopathological entities.
Irwin DJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
